相关实验视频

Updated: Jan 15, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

针对皮肤血管肉瘤的新型治疗方法,特别关注免疫检查点抑制剂

Yasuhiro Fujisawa¹

¹Department of Dermatology, Ehime University, Toon 791-0204, Japan.

|October 16, 2025

概括

晚期皮肤血管肉瘤 (CAS) 的全身治疗方法有限. 免疫检查点抑制剂 (ICI),特别是与氨酸激酶抑制剂 (TKI) 结合使用,对这种罕见的癌症显示出有前途.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
癌症研究癌症研究

背景情况:

皮肤血管肉瘤 (CAS) 是一种罕见的,具有不良预后的侵袭性癌症.
系统治疗对于不可切除或转移的CAS至关重要.
目前的治疗选择有效性有限.

研究的目的:

审查当前用于高级CAS的全身疗法.
讨论新兴策略,重点关注免疫检查点抑制剂 (ICI).

主要方法:

临床试验,回顾性研究和病例系列的综合文献综述.
对细胞毒性化疗,向疗法和ICI的分析.
关注生物标志物研究和正在进行的临床试验.

主要成果:

基于taxane的化疗 (例如,paclitaxel) 是一个标准的选择.
帕佐帕尼布显示适度的疗效.
在特定的子组中,ICI显示出令人鼓舞的结果 (例如,阳光暴露的瘤具有高瘤突变负担).
像TMB,PD-L1和TILs这样的生物标志物正在调查中.
目前正在探索组合疗法 (ICI + TKI).

结论:

对CAS的全身疗法有效性有限.
ICI,特别是与TKI结合,提供了一个有前途的治疗途径.
未来的研究应该专注于基于生物标志物的CAS特定策略.

关键词:

化学疗法化疗化疗皮肤血管肉瘤皮肤血管肉瘤免疫检查点抑制剂免疫检查点抑制剂辐射疗法辐射疗法手术手术手术手术手术手术手术有针对性的治疗.

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...